СОСТОЯНИЕ КОАГУЛЯЦИОННОЙ СИСТЕМЫ КРОВИ У БОЛЬНЫХ СИНДРОМОМ НОЧНОГО АПНОЭ

1. von Känel R, Loredo JS, Ancoli-Israel S, et al. Association between polysomnographic measures of disrupted sleep and prothrombotic factors // Chest. 2007;131:733–73.

2. von Känel R, Loredo JS, Ancoli-Israel S, et al. Association between sleep apnea severity and blood coagulability: treatment effects of nasal continuous positive airway pressure // Sleep Breath 2006; 10:139–14.

3. McNicholas WT, Bonsignore MR, et al. Sleep apnoea as an independent risk factor for cardiovascular disease: current evindence, basic mechanisms and research priorities // Eur Respir J. 2007;29:156-178.

4. Robinson GV, Pepperell JCT, Segal HC et al. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials // Sleep. 2004; 59:777-782.

5. von Känel R, Natarajan L, Anconi-Israel S et al. Day/Night rhythm of hemostatic factors in obstructive sleep apnea // Sleep. 2010; 33:371-377.

6. Takagi T, Morser J, Gabazza EC et al. The coagulation and protein C pathways in patients with sleep apnea // Lung. 2009; 187:209-213.

7. Akinnusi ME, Paasch LL, Szarpa KR et al. Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea // Respiration. 2009;77:25-31.

8. Atkeson A, Yeh SY, Malhotra A et al. Endothelial function in obstructive sleep apnea // Prog Cardiovasc Dis. 2009; 51:351-362.

9. El Solh AA, Akinnusi ME, Berim IG et al. Hemostatic implications of endothelial cell apoptosis in obstructive sleep apnea // Sleep Breath. 2008;12:331-337.

10. Zamarron C, Riccoy J, Riveiro A et al. Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension // Lung. 2008;186:151-156.

11. Steiner S, Jax T, Evers S et al. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk // Cardiology. 2005;104:92-96.

12. von Känel R, Loredo JS, Powell FL et al. Short-term isocapnic hypoxia and coagulation activation in patients with sleep apnea // Clin Hemorheol Microcirc. 2005;33:369-377.

13. Hrynkewicz-Szymanska A, Szymansky FM, Filipiak KJ et al. Can obstructive sleep apnea be a cause of in-stent thrombosis // Sleep Breath. 2010 May 23: online

14. Cohen S, Springer C, Peries Z et al. Cardiac, lung and brain thrombosis in a child with obstructive sleep apnea. Pediatr Pulmonol. 2010; 45:836-839.

15. Varol E, Ozturk O, Gonca T et al. Mean platelet volume is increased in patients with severe obstructive sleep apnea // Scand J Clin Lab Invest. 2010; 70:497-502.

16. Oga T, Chin K, Tabuchi A et al. Effects of obstructive sleep apnea with intermittent hypoxia on platelet aggregability // J Atheroscler Thromb. 2009; 16:862-869

17. Leroux des Jardins G, Glacet-Bernard A, Lasry S et al. Retinal vein occlusion and obstructive sleep apnea syndrome // J Fr Ophthalmol. 2009; 32:420-424.

18. Ishikawa J, Hoshide S, Eguchi K et al. Increased low-grade inflammation and PAI-1 level in nondippers with sleep apnea syndrome // J Hypertens. 2008; 26:1181-1187.

19. Epstein MD, Segal LN, Ibrahim SM et al. Snoring and the risk of obstructive sleep apnea in patients with pulmonary embolism // Sleep. 2010; 33:1069-1074.

20. Minoguchi K, Yokoe T, Tazaki T et al. Silent brain infarction and platelet activation in obstructive sleep apnea // Am J Respir Crit Care Med. 2007; 175:612-617.

21. Somers VK, White DP, Amin R et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology foundation scietific statement from the AHA council for high blood pressure research profeccional education committee, council on clinical cardiology, stroke council, and council on cardiovascular nursing in collaboration with the National Heart, Lung and Blood Institute National center on sleep disorders research (National Institutes of health) // Circulation. 2008;118:1080-1111.